Skip to content
Riskpilot
← Back to search
Sign in
Get full access
T.A.C. Thrombosis and Coagulation Consulting AB
AB
Active
Org 5565357398
Rental and operating of own or leased real estate
· NACE 6820
Est. 1996
0 employees
Watchlist
Share
Sweden
/
Companies
/
Rental and operating of own or leased real estate
/
T.A.C. Thrombosis and Coagulation Consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
12M
25M
37M
49M
26M
2021
34M
2022
17M
2023
19M
2024
43M
2025
EBITDA
SEK millions
0M
3M
5M
8M
10M
6M
2021
7M
2022
4M
2023
4M
2024
9M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
25 956
34 133
17 121
19 145
42 575
Staff expenses
—
—
—
—
—
EBITDA
5 834
7 442
3 643
4 329
9 060
Depreciation & amort.
−99
−99
−99
−99
−99
EBIT
5 735
7 343
3 544
4 230
8 961
Net financials
—
—
46
176
170
Profit before tax
5 095
5 914
3 109
4 070
7 490
Tax
−1 152
−1 281
−711
−932
−1 652
Net profit
3 943
4 633
2 398
3 138
5 838
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
95 895
101 976
102 720
106 481
114 447
Equity
28 076
32 708
35 107
38 245
44 083
Long-term debt
60 820
60 600
59 128
59 175
58 656
Short-term debt
428
668
6
244
1 251
Total debt
61 248
61 268
59 134
59 419
59 907
Financial ratios
5-year trend
EBITDA margin
21.3%
This company
15.8%
Market median
+35% vs market
2021
2025
Equity ratio
38.5%
This company
38.2%
Market median
+1% vs market
2021
2025
Return on equity
13.2%
This company
18.4%
Market median
+28% vs market
2021
2025
Net profit margin
13.7%
This company
8.1%
Market median
+69% vs market
2021
2025
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
2021
2025
Debt / equity
1.60×
This company
0.62×
Market median
-158% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
More on T.A.C. Thrombosis and Coagulation Consulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
